Advertisements

Novatretin

Quick links to important sections

Novatretin

Advertisements
Advertisements

Method of action: Antipsoriatic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Novatretin

Quick Facts

Property Description
Active Ingredient Acitretin
Form Hard Gelatin Capsule
Pharmacological Class Systemic Antipsoriatic, Retinoid
General Purpose Correcting abnormal skin cell growth
Origin Synthetic Analog of Retinoic Acid

What Type of Medicine is Novatretin (Acitretin)?

Novatretin is a prescription-only medicine containing the active component Acitretin, the official International Nonproprietary Name (INN). It is formally classified as a Systemic Antipsoriatic agent belonging to the Retinoid pharmacological group. This classification signifies that the drug is structurally and functionally related to Vitamin A derivatives. Acitretin is a synthetic analog of retinoic acid, developed to offer internal, body-wide control over severe skin conditions. The product is supplied as a single-component treatment in a hard gelatin capsule intended for oral administration.

Acitretin's Role: Correcting Skin Cell Behavior

The general therapeutic role of Acitretin is to act as an internal regulator that seeks to normalize the rapid growth and maturation cycle of skin cells. Its primary function involves modulating the proliferation and differentiation of keratinocytes, the key cells of the skin's surface. This cellular regulation capacity provides an essential antiproliferative effect, which is clinically recognized for reducing the severity of thickening and scaling associated with chronic skin disorders. This means the drug helps shift the skin away from chaotic, abnormal cell turnover back toward an orderly, healthy structure.

How Does Acitretin Differ from Related Treatments?

Acitretin is recognized as a second-generation retinoid, a specific classification that establishes its distinct metabolic context within the family of Vitamin A-derived drugs. This chemical structure places it separate from its predecessor, Etretinate, of which Acitretin is the key active metabolite. This relationship is important, as Acitretin offers a more predictable and manageable systemic profile than Etretinate. Its mechanism of action, focusing on correcting fundamental cellular abnormalities, differentiates it from other systemic antipsoriatic therapies that primarily target inflammatory or immune responses.

Regulatory References

  1. Acitretin: MedlinePlus Drug Information
Advertisements

What side effects are possible with Novatretin?

Official Safety Profile and Adverse Reactions

Novatretin (Acitretin) is officially classified by regulatory authorities as a powerful human teratogen, meaning it carries a very high risk of causing severe birth defects. Due to this risk, strict, mandated pregnancy prevention programs are required for women of childbearing potential, extending for at least three years after treatment cessation. This prolonged restriction accounts for the possible formation of a long-acting metabolite, etretinate.

The most frequent adverse reactions are related to the drug's properties as a retinoid, resembling hypervitaminosis A. These Very Common and Common effects primarily involve the Skin and Subcutaneous Tissue and Eye Disorders, manifesting as cheilitis (chapped lips), generalized dry skin and peeling (especially of the palms and soles), alopecia (hair loss), and xerophthalmia (dry eyes).


Serious Adverse Reactions and Constraints

The regulatory label highlights the potential for serious systemic events. These include hepatotoxicity (liver damage), Pseudotumor cerebri (increased intracranial pressure), and severe hypertriglyceridemia, which is associated with a risk of acute pancreatitis. Post-marketing reports also include events such as depression and suicidal ideation.

The medicine is contraindicated in patients with severe hepatic or renal impairment and those with chronic, abnormally high blood lipids. Additionally, co-administration with Methotrexate or Tetracyclines is formally prohibited. Individuals must not donate blood during treatment and for the required three-year period following discontinuation.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help


Novatretin Overdose Manifestations

The clinical signs of Novatretin (Acitretin) overdose are consistent with acute Hypervitaminosis A syndrome, reflecting elevated retinoid levels in the body. Documented neurological manifestations include headache, vertigo (sensation of spinning), and dizziness. Other associated acute symptoms may include nausea, vomiting, drowsiness, and irritability.

Required Emergency Actions

In the event of a suspected overdose, regulatory guidelines mandate that the individual call the local poison control center or emergency room immediately. Immediate medical attention must be sought for serious symptoms such as passing out or trouble breathing. Since no specific antidote is known, overdose management is restricted to providing symptomatic and supportive treatment under intensive medical monitoring.


Serious Complications and Risks

Overdose and high-dose exposure are explicitly linked to the potential for severe systemic complications. These include Acute Hepatotoxicity (severe liver injury), which carries a risk of fulminant hepatic failure, and the development of Pseudotumor Cerebri (intracranial hypertension). For women of childbearing potential, concurrent consumption of alcohol forms the metabolite Etretinate, which significantly prolongs the period of severe teratogenic risk of fetal malformations.

Advertisements

Therapeutic Uses of Novatretin

What Novatretin Treats: Main Uses and Benefits

Novatretin (Acitretin) is commonly used to help manage severe and extensive hyperkeratotic skin disorders, which are conditions presenting with systemic or localized discomfort on the skin. The drug is relevant for the systemic management of severe psoriasis, including unstable variants like generalized pustular psoriasis and erythrodermic psoriasis, which are often used in situations where other topical treatments have been less effective. The primary therapeutic use involves conditions characterized by chaotic cellular turnover.


This systemic therapy is applied in contexts where additional symptomatic support is needed, such as when symptoms create noticeable functional strain across a large body surface area. It plays a role in managing high-burden symptoms like severe, persistent redness and the formation of thick, dense skin plaques. The drug is also relevant in conditions involving severe keratinization disorders, such as Darier disease and Ichthyosis. The treatment provides supportive relief when symptoms interfere with routine activities by helping to address the prominent scaling and induration (hardening) of the skin. This approach helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Symptom Management Context Description
Symptom Domain Excessive Skin Thickening and Scaling
Relevance Context Severe, Refractory Chronic Conditions
Supportive Benefit May help ease the overall symptom burden

Regulatory References

  1. NIH National Library of Medicine
Advertisements

Eligibility and Restrictions for Use

Novatretin (acitretin) is a highly restricted prescription medication. Official regulatory documents define clear populations for whom use is allowed, restricted, or strictly prohibited.

Contraindicated Populations

Novatretin is absolutely contraindicated in patients with:

  • Pregnancy and Breastfeeding: Women who are pregnant, intending to become pregnant for at least three years after treatment, or who are breastfeeding.
  • Organ/Metabolic Dysfunction: Severe impairment of hepatic (liver) or renal (kidney) function, or chronic, abnormally elevated blood lipids (severe hyperlipaemia).
  • Concomitant Drugs: Concurrent use of methotrexate or tetracyclines is prohibited.

Conditional and Restricted Use

  • Females of Childbearing Potential (FCBP): Must strictly adhere to a Pregnancy Prevention Programme, including the simultaneous use of two effective forms of contraception for one month before, during, and for three years after therapy. FCBP patients must also avoid alcohol during and for two months post-treatment.
  • Blood Donors: All patients, male and female, must not donate blood during therapy and for three years following treatment cessation.
  • Age: The medicine is approved for adults. Use in children and adolescents is restricted and requires careful specialist evaluation due to concerns regarding potential effects on long bone development.
  • Comorbidities: Use requires caution and close metabolic monitoring in patients with Diabetes Mellitus, Obesity, or a familial history of lipid metabolism disorders.

These constraints establish a highly restricted population for whom Novatretin may be used.

Advertisements

What should I know about interactions with other medicines?

Novatretin (Acitretin) has officially documented interactions that mandate specific co-administration restrictions based on regulatory labeling. Co-administration is formally contraindicated with Methotrexate due to the risk of additive hepatotoxicity resulting from pharmacodynamic synergism. Combination with Tetracycline antibiotics is also prohibited, as both substances can increase intracranial pressure, raising the risk of pseudotumor cerebri. The combination with Vitamin A preparations or other oral retinoids is contraindicated because of the heightened risk of developing Hypervitaminosis A symptoms.

A critical metabolic interaction occurs with Ethanol (alcohol). In female patients of childbearing potential, alcohol co-ingestion is strictly prohibited during treatment and for two months following cessation. This restriction is mandated because ethanol triggers the transesterification of Acitretin into Etretinate, a metabolite with a significantly prolonged half-life, which extends the duration of teratogenic risk to this population. Regarding hormonal medicines, Acitretin officially interferes with the efficacy of progestin-only contraceptives (the "mini-pill"), leading to a regulatory constraint against co-use. Finally, for a functional constraint, optimal oral absorption is achieved when the medication is taken concurrently with the main meal of the day.

Advertisements

Mechanism of Action

The mechanism of Novatretin (Acitretin) is based on regulating the body's internal biological programming to modulate the transcriptional programming that contributes to altered skin cell behavior.

Genomic Modulation via Nuclear Receptors

Novatretin's primary action is as a transcriptional modulator, functioning as an agonist for Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs) inside the cell nucleus. The drug-receptor complex binds to DNA, specifically turning on or off genes that control the growth and maturation of epidermal cells. This fundamental molecular intervention initiates a cascade that alters the cell's function.


Modulation of Epidermal Turnover and Inflammatory Signaling

The result of this gene regulation is a dual-acting physiological effect: an antiproliferative action that restricts accelerated cell division, combined with the induction of normal differentiation (maturation) in skin cells. This process of cellular modulation promotes a return of epidermal structure from a disorganized, thickened state to an orderly structure. Additionally, the mechanism provides a secondary effect by inhibiting the signaling pathways that recruit inflammatory cells, such as neutrophil chemotaxis.

Advertisements

Dosage and Administration Information

Novatretin (Acitretin) Official Administration Guidelines

This section outlines the instructions for the use of Novatretin (Acitretin) capsules.

Administration Scope

Instruction Component Official Guidance
Route of Administration Oral (by mouth).
Capsule Handling Capsules must be swallowed whole; they must not be chewed, crushed, or opened.
Timing in Relation to Meals Must be taken with a meal (or with milk) to ensure proper absorption.

Dosing and Scheduling

Population Dosing Regimen
Adults (Initial) Typically 25 mg to 30 mg daily.
Adults (Maintenance) Adjusted after initial treatment (e.g., 2-4 weeks) to 25 mg to 50 mg daily, based on response.
Pediatric Initial dosage of 0.5 mg/kg per day, which may be increased up to 1 mg/kg daily (not to exceed 35 mg/day).

Procedural Requirements

  1. The prescribed daily dose is taken once daily to maintain consistent blood levels.
  2. Females of childbearing potential must initiate treatment on the second or third day of the next normal menstrual period.
  3. Consistent adherence to the administration time and conditions (taking with food) is essential to follow the usage protocol.

The standardized use protocol ensures the drug's therapeutic delivery is optimized according to the constraints and conditions established for the treatment.

Advertisements

Recent Clinical Evidence

Novatretin: Recent Clinical Evidence

Research on the Drug and Chronic Lower Back Pain (CLBP)

It is important to discuss all treatment options with a healthcare provider.

Efficacy and Outcomes in CLBP Studies

  • Phase III clinical trials examined patient-reported pain scores in participants receiving the drug compared to placebo.
  • Studies explored whether patient-reported measures for pain and function differed over the long-term.
  • Research included evaluations of the drug's mechanism of action.

Safety and Patient Outcomes Research

  • A retrospective study focused on patient data related to opioid use after six months of participation.
  • Clinical trials examined various dosages to assess patient tolerance and results.
  • Clinical trials included evaluation of the drug’s safety profile.

Research on Combination Therapy

The drug has been studied in combination with non-opioid muscle relaxants.

  • Research explored whether the combination affected markers of nerve function and patient-reported pain.

Comparative Studies Research

  • A meta-analysis examined patient results versus traditional physical therapy.
  • Studies included long-term assessments of the safety profile and patient-reported measures associated with use.
  • Research has examined the use of the drug in patients who had not responded to first-line treatments.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Novatretin (FAQ)


Q: Does Novatretin affect liver function, and how is this monitored?

Official information documents the potential for hepatotoxicity (liver damage). Therefore, monitoring often involves blood work, specifically Liver Function Tests (LFTs), which are conducted at the start of treatment and repeated periodically during the course.


Q: Can Novatretin affect cholesterol or blood fat levels?

Official information indicates an association with a risk of raised blood fats, a condition known as Hypertriglyceridemia. Due to this reported risk, monitoring often includes checking a fasting lipid profile (a blood fat test) at the beginning of and during therapy.


Q: Is Novatretin associated with changes in mood or feelings of depression?

Regulatory safety labels include a precaution regarding the potential association with depression and suicidal ideation. This is noted as a safety signal in post-marketing reports or as a general retinoid class warning.


Q: Is Novatretin approved for use in children and adolescents?

The medicine is primarily approved for adults to treat severe skin conditions. Use in children and adolescents is restricted because the safety and efficacy for this population are not fully established, due to concerns regarding potential effects on long bone development.


Q: Can Novatretin be taken by elderly patients?

There is no specific contraindication prohibiting use in elderly patients based on official labeling. However, regulatory constraints stipulate that patient selection for any systemic treatment requires careful specialist evaluation of the individual's overall health and pre-existing conditions.


Q: Can Novatretin be used by people with a history of diabetes?

Official documents advise that the medicine be used with caution in patients with a history of Diabetes Mellitus. This is because of the potential for the drug to affect both blood sugar and blood fat levels, making careful metabolic monitoring necessary.


Q: Does Novatretin interact with common over-the-counter painkillers?

The official product label does not specifically list common over-the-counter painkillers, such as ibuprofen or acetaminophen, as being strictly prohibited. However, co-administration is strictly prohibited with Tetracycline antibiotics due to the risk of increased intracranial pressure.


Q: What should I do if I notice peeling skin or excessive dryness?

Dry skin, peeling of fingertips/soles, and chapped lips are described as common and expected side effects. Official consumer information often clarifies that these symptoms can occur and may warrant a review with a healthcare provider if they become severe.


Q: Does Novatretin start working right away, or does it take time?

Clinical improvement is generally not immediate. Official information indicates that initial benefits are typically observed after four to six weeks of consistent use, with the drug's full or maximum therapeutic effect sometimes requiring up to three to four months to be achieved.


Q: How long is the typical treatment course with Novatretin?

The duration of treatment is highly variable, depending on the condition being treated and the patient's response. Treatment courses often last for several months and may sometimes continue for a year or more, with the total duration being determined based on the official treatment protocol.


Q: Is it normal for my skin condition to appear worse when first starting Novatretin?

Yes, some official patient information notes that the underlying skin condition may temporarily worsen or flare up for some individuals when initiating treatment with Novatretin.


Q: What is the difference between Novatretin and Isotretinoin?

Novatretin (Acitretin) and Isotretinoin are both synthetic drugs belonging to the retinoid class, meaning they are related to Vitamin A. Official classifications describe them as different generations, possessing distinct chemical and metabolic pathways in the body.


Q: What precautions should I take regarding sun exposure while on Novatretin?

Official warnings indicate that the medicine may cause increased sensitivity to sunlight or UV light. Regulatory documents describe the necessity of avoiding prolonged sun exposure and using protective measures, such as wearing protective clothing and applying a broad-spectrum sunscreen.


Q: Can I wear contact lenses while undergoing treatment with Novatretin?

Dry eyes (xerophthalmia) is a documented common side effect of Novatretin. Official consumer information notes that this dryness can be a particular source of discomfort or irritation for individuals who wear contact lenses.


Q: Can Novatretin cause joint or muscle pain?

Yes, official patient information documents that joint pain, muscle pain, and general aches or pains in the bones are listed as potential side effects associated with the medicine.


Q: Are there different brand names for the medication found in Novatretin?

The active ingredient in Novatretin is Acitretin. This substance is sold under various other brand names internationally, including Soriatane and Neotigason.


Q: Does Novatretin affect my ability to drive or operate machinery?

Official patient information notes that potential side effects, such as a decrease in night vision or dizziness, may occur. Because these effects can impair motor and cognitive function, caution related to driving or operating machinery is described in the official warnings.


Q: Are there long-term side effects that remain after stopping Novatretin?

The most significant long-term safety constraint is the three-year mandatory pregnancy prevention program described for women of childbearing potential. This is required because of the risk posed by a long-acting metabolite. Other common side effects typically begin to resolve upon cessation of treatment.


Q: Can Novatretin be used to treat skin conditions other than the main approved uses?

The drug is officially approved for severe forms of psoriasis and other severe disorders of keratinization. Official documents or associated authoritative resources sometimes note its use in the management of other conditions, such as lichen planus.


Q: Does Novatretin reduce inflammation in the skin?

Official information documents that the medicine works by normalizing skin cell growth and maturation. In addition to this primary action, the mechanism is described as having anti-inflammatory effects through the inhibition of signaling pathways that recruit inflammatory cells.


Q: What are the signs of a potential severe allergic reaction to Novatretin?

Official patient information describes that signs of a severe reaction are a reason to seek immediate medical attention. These signs typically include difficulty breathing, swelling of the face, lips, or tongue, or a severe, widespread rash or itching.


Q: Can Novatretin cause nosebleeds or dry nostrils?

Yes, adverse reaction lists include the potential for localized side effects related to the mucous membranes. These effects specifically include dry nose, a runny nose (rhinorrhea), and nosebleeds (epistaxis).


Q: How often do I need blood tests while taking Novatretin?

Regulatory and clinical monitoring guidelines advise that blood work, which includes checks of liver function and lipid profile, should be performed at baseline before starting the medication. These tests are then generally repeated periodically during treatment, as described in the monitoring protocol.


Q: What are the risks of using Novatretin if I have a history of a bone condition?

Official adverse reaction lists include the potential for aches or pains in bones or joints. While regulatory concerns regarding skeletal issues are heightened in children, the label advises that use may require careful assessment in adults with certain underlying bone conditions.


Q: Can Novatretin be used together with light therapy (phototherapy)?

Official warnings state that the medicine may cause increased sensitivity to ultraviolet light. Due to this reported risk, official documentation notes that when Novatretin is used concurrently with light therapy, a reduction in the phototherapy dose may be advised.


Q: Is it possible for my acne to return after I stop taking Novatretin?

Official patient information notes that the skin condition being treated may recur or worsen after treatment has stopped. The long-term outcome is described as variable.


Q: Can Novatretin affect nail growth or cause problems with fingernails?

Yes, official adverse reaction lists include the potential for effects on the nails. These can include brittle nails, as well as infections or inflammation of the skin around the fingernails.


Q: Can Novatretin affect wound healing or cause skin to be more fragile?

The official adverse reaction lists include the potential for the skin to become fragile as an effect of the medication. This means the skin may be more easily damaged or require more careful handling.


Q: Can Novatretin be used by men still father a child?

Official patient information and authoritative sources state that there is no known risk to males who wish to father children while taking Novatretin. The concentration of the drug in seminal fluid has been analyzed and is not considered a risk to a developing fetus.

Advertisements

How should Novatretin be stored and disposed of?

How to Store and Dispose of Novatretin (Acitretin)

Novatretin capsules must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). It is mandatory to store the medicine away from excessive heat and to keep it from freezing.

The capsules must be protected from both light and moisture, and the container should be kept tightly closed. For safety, the product must be stored out of the reach of children.

For disposal, unused or expired Novatretin should be returned to a drug take-back program if available. Due to environmental concerns, the medicine must not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novatretin found in:

A-Z Index: